A Massachusetts chipmaker plans to pump millions of dollars into upgrades at a Durham facility — the latest plan fueled by a ...

AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs.

Days before the Biden administration's term ends, the U.S. Commerce Department approved a $70 million CHIPS and Science Act grant that will again benefit the Triangle region. Why it matters: The grant ...

Resilience, a private company, in 2021 agreed to buy the Durham facility as part of a $110 million deal that involved taking over manufacturing and 100 employees from Bluebird Bio. Bluebird ...

DURHAM, N.C. (WTVD) -- The U.S. Department of Commerce announced that CHIPS for America awarded the Semiconductor Research Corporation Manufacturing Consortium Corporation (SRC) $285 million to ...

bluebird bio, a Massachusetts-based gene and cell therapy company, has opened its first wholly owned manufacturing facility in Durham amid cheers from state leaders. “North Carolina is proud to bring ...

manufacturing, packaging, assembly and test processes. Commerce is investing about $285 million to establish and operate the institute in Durham. The company, which competes with Broadcom ...

30,161 people played the daily Crossword recently. Can you solve it faster than others?30,161 people played the daily Crossword recently. Can you solve it faster than others?